Literature DB >> 9271359

Journey from cachexia to obesity by TNF.

J M Argilés1, J López-Soriano, S Busquets, F J López-Soriano.   

Abstract

Tumor necrosis factor-alpha (TNF-alpha) is a cytokine involved in the physiological and metabolic abnormalities found in cachectic states. Until very recently, it was inconceivable to think of TNF-alpha in obesity. However, recent studies have shown that TNF-alpha can also play a key role in obesity, the cytokine being overexpressed in adipose tissue of obese rodents and humans. The aim of this review is to reconcile the role of TNF-alpha in these two opposite metabolic situations: obesity and cachexia. It is suggested that TNF-alpha may have a key role in the control of body mass in normal weight-controlled situations and that abnormalities in either its production (during cachexia) or action (during obesity) are responsible for the lack of control of body weight.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9271359     DOI: 10.1096/fasebj.11.10.9271359

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  14 in total

Review 1.  Hormonal regulation of physiological cell turnover and apoptosis.

Authors:  R D Medh; E B Thompson
Journal:  Cell Tissue Res       Date:  2000-07       Impact factor: 5.249

2.  Ageing, tumour necrosis factor-alpha (TNF-alpha) and atherosclerosis.

Authors:  H Bruunsgaard; P Skinhøj; A N Pedersen; M Schroll; B K Pedersen
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

3.  Changing shape of disease: nonalcoholic fatty liver disease in Crohn's disease-a case series and review of the literature.

Authors:  Christopher E McGowan; Patricia Jones; Millie D Long; A Sidney Barritt
Journal:  Inflamm Bowel Dis       Date:  2011-02-23       Impact factor: 5.325

4.  Family and case-control association study of the tumor necrosis factor-alpha (TNF-alpha) gene with schizophrenia and response to antipsychotic medication.

Authors:  Gwyneth Zai; Daniel J Müller; Jan Volavka; Pal Czobor; Jeffrey A Lieberman; Herbert Y Meltzer; James L Kennedy
Journal:  Psychopharmacology (Berl)       Date:  2006-08-24       Impact factor: 4.530

5.  Serum leptin, adiponectin and tumor necrosis factor-α in hyperlipidemic rats with/without concomitant diabetes mellitus.

Authors:  Angeliki Margoni; Despoina N Perrea; Ioannis Vlachos; Georgia Prokopaki; Alkistis Pantopoulou; Lambros Fotis; Maria Kostaki; Athanasios G Papavassiliou
Journal:  Mol Med       Date:  2010-09-08       Impact factor: 6.354

6.  Circulating white blood cell count and measures of adipose tissue inflammation predict higher 24-h energy expenditure.

Authors:  Jianying He; Duc Son Le; Xiaoyuan Xu; Michael Scalise; Anthony W Ferrante; Jonathan Krakoff
Journal:  Eur J Endocrinol       Date:  2009-11-24       Impact factor: 6.664

Review 7.  Genes and genomics of autoimmune inflammation: from Rel to TRAIL.

Authors:  Youhai H Chen
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

8.  Stress and body mass index each contributes independently to tumor necrosis factor-alpha production in prepubescent Latino children.

Authors:  Denise Dixon; Hongdao Meng; Ronald Goldberg; Neil Schneiderman; Alan Delamater
Journal:  J Pediatr Nurs       Date:  2008-09-04       Impact factor: 2.145

9.  Adiponectin multimers in maternal plasma.

Authors:  S Mazaki-Tovi; R Romero; J P Kusanovic; O Erez; E Vaisbuch; F Gotsch; P Mittal; G N Than; C Nhan-Chang; T Chaiworapongsa; S Edwin; N Camacho; J K Nien; S S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2008-11

10.  Infliximab in ulcerative colitis.

Authors:  Avi Levin; Oren Shibolet
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.